University of South Carolina

Scholar Commons
Faculty Publications

Epidemiology and Biostatistics

5-30-2011

Cardiometabolic results from an armband-based weight loss trial
John C. Sieverdes
Xuemei Sui
University of South Carolina - Columbia, msui@mailbox.sc.edu

Gregory A. Hand
University of South Carolina - Columbia, ghand@sc.edu

Vaughn W. Barry
Sarah Wilcox
University of South Carolina - Columbia, swilcox@sc.edu

See next page for additional authors
Follow this and additional works at: https://scholarcommons.sc.edu/
sph_epidemiology_biostatistics_facpub
Part of the Public Health Commons

Publication Info
Published in Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Volume 4, 2011, pages
187-194.
Sieverdes, J. C., Sui, X., Hand, G. A., Barry, V. W., Wilcox, S., Meriwether, R. A., ... Blair, S. N. (2011).
Cardiometabolic results from an armband-based weight loss trial. Diabetes, Metabolic Syndrome and
Obesity: Targets and Therapy, 4, 187-194.
DOI: 10.2147/DMSO.S18649
© Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 2011, Dove Medical Press
http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journal

This Article is brought to you by the Epidemiology and Biostatistics at Scholar Commons. It has been accepted for
inclusion in Faculty Publications by an authorized administrator of Scholar Commons. For more information, please
contact digres@mailbox.sc.edu.

Author(s)
John C. Sieverdes, Xuemei Sui, Gregory A. Hand, Vaughn W. Barry, Sarah Wilcox, Rebecca A. Meriwether,
James W. Hardin, Amanda C. McClain, and Steven N. Blair

This article is available at Scholar Commons: https://scholarcommons.sc.edu/
sph_epidemiology_biostatistics_facpub/406

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

Dovepress

open access to scientific and medical research

O r i g i n al R e s e a r c h

Open Access Full Text Article

Cardiometabolic results from an armband-based
weight loss trial
This article was published in the following Dove Press journal:
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
28 May 2011
Number of times this article has been viewed

John C Sieverdes
Xuemei Sui
Gregory A Hand
Vaughn W Barry
Sara Wilcox
Rebecca A Meriwether
James W Hardin
Amanda C McClain
Steven N Blair
Department of Exercise Science,
University of South Carolina,
Columbia, SC, USA

Purpose: This report examines the blood chemistry and blood pressure (BP) results from the
Lifestyle Education for Activity and Nutrition (LEAN) study, a randomized weight loss trial.
A primary purpose of the study was to evaluate the effects of real-time self-monitoring of
energy balance (using the SenseWearTM Armband, BodyMedia, Inc Pittsburgh, PA) on these
health factors.
Methods: 164 sedentary overweight or obese adults (46.8 ± 10.8 years; BMI 33.3 ± 5.2 kg/m2;
80% women) took part in the 9-month study. Participants were randomized into 4 conditions:
a standard care condition with an evidence-based weight loss manual (n = 40), a group-based
behavioral weight loss program (n = 44), an armband alone condition (n = 41), and a group plus
armband (n = 39) condition. BP, fasting blood lipids and glucose were measured at baseline
and 9 months.
Results: 99 participants (60%) completed both baseline and follow-up measurements for BP
and blood chemistry analysis. Missing data were handled by baseline carried forward. None
of the intervention groups had significant changes in blood lipids or BP when compared to
standard care after adjustment for covariates, though within-group lowering was found for
systolic BP in group and group + armband conditions, a rise in total cholesterol and LDL
were found in standard care and group conditions, and a lowering of triglycerides was found
in the two armband conditions. Compared with the standard care condition, fasting glucose
decreased significantly for participants in the group, armband, and group + armband conditions
(all P , 0.05), respectively.
Conclusion: Our results suggest that using an armband program is an effective strategy to
decrease fasting blood glucose. This indicates that devices, such as the armband, can be a successful way to disseminate programs that can improve health risk factors. This can be accomplished
without group-based behavioral programs, thereby potentially reducing costs.
Keywords: armband, energy balance, randomized controlled trial, physical activity, blood
lipids, blood glucose
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Prior reports of participation in physical activity (PA) interventions1–5 have observed
favorable changes in physiological risk factors. These reports led to the 2008 publication
of the “Physical Activity Guidelines for Americans,” which documents that most health
benefits result from at least 150 minutes of moderate activity a week, 75 minutes of
vigorous activity a week, or a combination of the two along with two or more days of
muscle-strengthening activities that work all major muscle groups.6 Risk factors such as
elevated levels of blood pressure (BP), blood lipids, and glucose play an important role
in determining risk of developing chronic diseases or death.7–11 Prior PA intervention
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011:4 187–194
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studies using technology tools (eg, pedometers) have used
paper-based materials, such as in the First Step Program,12 or
have used groups to teach cognitive and behavioral strategies
to increase PA.13 Fewer studies have utilized technologybased approaches to promote weight loss and PA.14–18 It is
important to examine new methods using the latest technology to provide feedback to participants in a study that is
readily available, and flexible to their goals. The ability to
use real-time feedback monitoring of energy expenditure
may be a useful strategy to enable success in a wide variety
of populations through its interactive nature, and must be
studied more closely.
To our knowledge, relatively few randomized controlled
trials (RCT) have examined technology-based weight loss
approaches to improve BP, blood lipids, and glucose.12,14,16,17,19,20
The Lifestyle Education for Activity and Nutrition (LEAN)
study was a 9 month RCT to determine the effectiveness of
using the SenseWearTM Armband (BodyMedia, Inc Pittsburgh,
PA) for weight loss among 164 sedentary and overweight or
obese individuals. While weight loss was the primary outcome of LEAN, BP, blood lipids, and fasting glucose were
a priori secondary outcomes.21 The LEAN study provided
an opportunity to examine the effects of various weight loss
approaches on these selected cardiometabolic factors. Therefore, the primary aim of this report was to examine changes in
BP, fasting blood lipids, and fasting glucose across different
intervention conditions. Findings from this study will further
our understanding of utilizing real-time self-monitoring devices
on physiological outcomes.19

Methods
Study design
A complete description of the LEAN study design and methods appears elsewhere.21 In brief, the study was a RCT with
a standard care control condition and 3 treatment conditions.
The treatment conditions consisted of a group behavioral
change intervention based on the transtheoretical model
and social cognitive theory22 (group), an armband alone
condition (armband), and a combined group-based weight
loss intervention and armband condition (group + armband).
The research protocol was reviewed and approved annually
by the University of South Carolina Institutional Review
Board. Written informed consent was obtained from all
participants.

Study participants
Thorough descriptions of the recruiting and screening processes, as well as the methods are available.21 Briefly, the
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study was limited to men and women aged 18 to 65 years who
were sedentary (not accumulating 150 minutes of moderate
to vigorous PA throughout the week in bouts $10 minutes),
overweight or obese (body mass index [BMI] between
25.0–45.0 kg/m2), and with access to the internet. Exclusion criteria included significant weight loss (.20 lbs) in
the prior 6 months; elevated BP ($160/95 mm Hg); current
participation in a formal weight loss program; using medications that affect weight; and ailments, medical conditions or
other issues (eg, pregnancy) that limit PA or would prevent
participants from adhering to the protocol. Individuals with
a score of 16 or more on the Center for Epidemiological
Studies Depression scale were excluded based on data from
other studies demonstrating that depressed mood is associated with attrition from weight loss programs.23 Participants
were recruited from the greater Columbia, South Carolina
area from February 2008 to January 2009.

Outcomes
All LEAN study staff were trained by the same supervisor
to minimize inter-technician variability. Blood lipids and
glucose were measured at baseline and 9-month assessment
visits. Participants were instructed to fast (ie, no food or
drink after midnight, besides water) for these assessments.
All blood draws occurred between 7.00 am and 9.30 am and
were taken from the antecubital vein. Serum samples were
processed and analyzed using standardized procedures by
a Versamax microplate reader (Molecular Devices, Inc,
Sunnyvale, CA) using Pointe Scientific, Inc (Canton, MI)
reagents and standards, to measure total cholesterol (TC),
high-density lipoprotein (HDL), and triglycerides. Very-lowdensity lipoprotein (VLDL) was first calculated by dividing
the triglyceride count by 5. Then the following equation was
used to calculate low-density lipoprotein (LDL):
TC − HDL − VLDL = LDL

(1)

Three supine readings of BP were taken alternately after
a 5-minute supine resting period and averaged. BP was
measured using calibrated mercury sphygmomanometers
following the JNC7 protocol.24

Other measures
Body weight to the nearest 0.25 lbs was assessed using a
calibrated balance-beam scale. Height to the nearest 16th
of an inch was assessed using a wall-mounted stadiometer.
Smoking history and medication use were assessed by
responses on detailed medical history questionnaires and
reviewed by a physician.

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011:4

Dovepress

Intervention
Participants were randomly assigned to either the standard
care control condition or to one of the intervention conditions:
group, armband, or group + armband.
Standard Care: These participants received a self-directed
weight loss manual based on two evidence-based programs,
Active Living Every Day (ALED)25 and Healthy Eating
Every Day (HEED).26 The manual’s focus was to help individuals adopt healthful eating patterns and increase their PA
levels. Cognitive and behavioral strategies consistent with
the transtheoretical model and social cognitive theory were
emphasized.27,28 All study participants received this manual.
Group: During the 9-month intervention, participants received
14 group sessions during the first 4 months, then 6 one-onone telephone counseling sessions over the final 5 months.
Each group session followed the ALED and HEED curriculum format from the manual, with the addition of a weekly
weigh-in and more content directly related to weight loss. The
one-on-one telephone counseling sessions were designed to
promote the maintenance of behavior change.
Armband: The armband condition received the SenseWearTM
platform consisting of the SenseWearTM Armband, a wrist
watch with real-time display, and access to a personalized
Weight Management Solutions web account. While wearing
the armband and wrist watch display, participants received
real-time feedback on several outcomes (ie, energy expenditure, minutes spent in moderate and vigorous PA, steps per
day, progress towards goals). Feedback could be reviewed
graphically (eg, energy intake, energy balance, and weight
loss) as participants regularly downloaded their PA data
and recorded daily energy intake and body weight to the
Weight Management Solutions web account. Participants
were asked to wear the armband at least 16 hours a day,
7 days a week.
Group + Armband: These participants received all components of the group condition with the addition of the
SenseWearTM platform in the armband condition.

Participant retention, adherence, blinded
assessment, and randomization
To facilitate retention and adherence, participants completed a 2-week pre-randomization run-in period and
received a printed list of study requirements and expectations. Participants were compensated for completion of the
baseline and month 4 assessment (US $10) and month 9
assessment (US $15), totaling US $25. Assessment personnel
were blinded to intervention assignment. Participants were
reminded not to discuss their condition assignment with the
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assessment team. Randomization assignment was computer
generated and conducted by the statistician.

Statistical analysis
Descriptive baseline characteristics for conditions were
tabulated as means and standard deviations (SD) or as
percentages. Differences in blood chemistry and BP changes
within and across conditions were tested by analysis of
covariance with adjustment for baseline age, gender, race,
education, recruitment wave, and baseline lipid values.
Furthermore, BP and lipid measures were adjusted for baseline medications affecting the respective outcomes. An α
level of 0.05 was used because it was an a priori intention
to compare only the differences between the intervention
conditions and the standard care condition.21 Results are
presented as adjusted means with standard error (SE) or 95%
confidence intervals (CI).
For comparison, all outcomes were tested using only
available data, without using baseline values carried forward
for missing follow-up data. The results from these analyses
did not differ substantially from the analyses with baseline
values carried forward. For presentation herein, we report
the baseline observation carried forward analyses using
SAS statistical software, version 9.2 (SAS Inc, Cary, North
Carolina).

Results
A total of 787 telephone screening calls were completed.
Based on exclusion and inclusion criteria, 590 potential
participants (75%) were ineligible (Figure 1). After giving
informed consent, 197 (25%) were randomized, of whom
164 (83%) had complete data at baseline. One hundred and
four (63%) completed the study with 99 providing usable
follow-up data (60%). Baseline values were carried forward
for missing data or dropouts, so data from 164 of 197 participants (83%) were included in the primary analyses.
The mean age was 47.6 ± 10.7 (SD) years and mean
BMI 33.2 ± 5.3 (SD) kg/m2 for the participants in the
study population, with 31.1% being African American
(Table 1). About a third (31.1%) of the participants took
medication for hypertension, and 26.8% were currently
prescribed lipid lowering medication. Very few participants
were taking medication for high blood glucose (7.3%).
Only 4.9% of participants were current smokers, and a high
percentage of participants (77.4%) were college graduates.
Cardiovascular risk factors were within normal ranges.
Table 2 presents the changes in BP and lipid variables.
Compared with the standard care condition, none of the
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787 Individuals screened

272 Excluded
5 For BMI <25 or >45
36 For medical exclusions
20 For CESD
211 Declined to participate/other

510 Individuals eligible for
orientation visit

238 Individuals eligible for
run-in visits

277 Ineligible or not interested
2 For age criteria
84 For BMI <25 or >45
32 For being too active
54 For medical exclusions
10 For internet access
48 For weight loss exclusions
13 For activity limitations
34 Declined to participate/other

14 Excluded
3 For blood pressure
4 For activity logs
7 Declined to participate/other

224 Individuals eligible
for baseline visit
27 Excluded
3 For BMI <25 or >45
24 Declined to participate/other
197 Randomized

50 Randomized to Standard Care

49 Randomized to Group

49 Randomized to Armband

49 Randomized to Group+Armband

40 Completed Baseline Blood
Draw

44 Completed Baseline Blood
Draw

41 Completed Baseline Blood
Draw

39 Completed Baseline Blood
Draw

25 Completed Trial

28 Completed Trial

24 Completed Trial

27 Completed Trial

23 Follow-up Blood available

24 Follow-up Blood available

26 Follow-up Blood available

26 Follow-up Blood available

40 Included in primary analysis

44 Included in primary analysis

41 Included in primary analysis

39 Included in primary analysis

Figure 1 Consolidated Standards of Reporting Trials (CONSORT) diagram describing recruitment and retention of participants. If follow-up blood chemistry were missing,
baseline values were carried forward.

intervention conditions had significant changes in BP or
lipids in analyses adjusted for baseline value, age, gender, race,
education, medication, and recruitment wave. When groups
were stratified by medication, these results did not differ (data
not shown). Lower systolic blood pressures were found within
the group (−2.96 mm Hg) and group + armband (-3.48 mm
Hg) conditions (all P , 0.05). Significant within-group
increases of TC and LDL were found in standard care (TC
change, 18.32 mg/dL; LDL change, 15.84 mg/dL) and group
(TC change, 15.58 mg/dL; LDL change, 13.71 mg/dL) conditions, respectively (all P , 0.05). There were also significant
within-group decreases in triglycerides in both the armband
(−13.07 mg/dL) and group + armband (-19.87 mg/dL) conditions (all P , 0.05).
Figure 2 shows the mean change for fasting glucose for all
conditions. Due to the low number of participants taking medication for blood glucose (n = 12), those persons were excluded,
leaving 152 in the analysis. All values represent the least-squares
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means adjusted for age, gender, race, education, recruitment
wave, and baseline glucose level. Compared with the standard
care condition, mean glucose decreased by 5.42 mg/dL in
the group condition, 8.88 mg/dL in the armband condition,
and 12.59 mg/dL in the group + armband condition. Pairwise
comparisons between standard care and group, armband, and
group + armband conditions were significant (P , 0.05).

Discussion
The primary finding from this RCT was a favorable reduction
in fasting glucose in the treatment conditions. All treatment
conditions showed a significant reduction when compared
with the standard care condition. Only within-group conditions for group and group + armband were found for lower
blood pressure. Other changes included within group lowering of triglycerides for the armband and group + armband
treatments. Though not anticipated, the standard care and
group treatments had unexpected higher TC and LDL values

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2011:4
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Table 1 Baseline characteristics*
Characteristics

Total
(n = 164)

Standard care
(n = 40)

Group
(n = 44)

Armband
(n = 41)

Group + Armband
(n = 39)

Age (years)
Female, No. (%)
African American, No. (%)
College degree or
higher, No. (%)
Body mass index (kg/m2)
Resting blood pressure (mmHg)
Systolic
Diastolic
Fasting plasma lipids (mg/dL)
Total cholesterol
HDL
LDL
Triglycerides
Fasting blood glucose (mg/dL)
Current smoker, No. (%)
Current medication, No. (%)
Hypertension
Diabetes mellitus
Lipids lowering medication†

47.6 (10.7)
132 (80.5)
51 (31.1)
127 (77.4)

47.8 (9.0)
33 (82.5)
15 (37.5)
31 (77.5)

46.8 (12.4)
35 (79.6)
13 (29.6)
35 (79.6)

49.2 (11.4)
32 (78.1)
12 (29.3)
32 (78.1)

46.6 (9.6)
32 (82.1)
11 (28.2)
29 (74.4)

33.2 (5.3)

33.9 (5.6)

32.8 (4.9)

33.4 (5.7)

32.7 (5.0)

127 (12)
81 (8)

129 (13)
82 (9)

126 (11)
79 (8)

129 (13)
81 (8)

125 (12)
79 (7)

173.3 (44.2)
47.8 (19.4)
105.5 (42.5)
99.6 (64.9)
97.7 (24.8)
8 (4.9)

171.8 (34.2)
48.5 (20.3)
102.5 (33.0)
103.9 (67.7)
99.1 (18.3)
4 (10)

170.8 (48.3)
47.5 (18.8)
103.2 (46.2)
100.6 (66.5)
104.0 (29.6)
1 (2.3)

178.1 (47.5)
45.4 (19.5)
111.2 (45.2)
107.6 (71.5)
98.0 (21.9)
2 (4.9)

172.5 (46.1)
50.2 (19.4)
105.2 (44.8)
85.6 (51.6)
88.8 (26.0)
1 (2.6)

51 (31.1)
12 (7.3)
44 (26.8)

11 (27.5)
1 (2.5)
7 (17.5)

11 (25.0)
5 (11.4)
13 (29.6)

16 (39.0)
4 (9.8)
15 (36.6)

13 (33.3)
2 (5.1)
9 (23.1)

Notes: *Data presented as mean (standard deviation) unless otherwise indicated. †Lipids lowering medication includes Statin and triglycerides-medications.
Abbreviations: HDL, high-density lipoprotein; LDL, low-density lipoprotein.
SI conversions: To convert LDL and HDL to mmol/L, multiply by 0.0259; triglycerides to mmol/L, multiply by 0.0113; fasting glucose to mmol/L, multiply by 0.0555.

after 9 months. We speculate that this may have resulted
from a change or discontinuation of medications, not following the fasting procedures, body weight changes, or other
unknown causes. No differences were found between the group
intervention, the armband alone, or a combination of the two
on glucose. Overall, these findings suggest that a technologybased intervention with an armband, used as a real-time
self-monitoring device, is a sufficient behavior change strategy
for reducing fasting blood glucose after 9 months.

Comparison to other studies
Several studies incorporating technology-based devices
using real-time feedback in their behavioral change strategies
have focused on PA and weight changes in their designs.15,18

Few studies have included cardiometabolic changes.12,14,16,17,19,20
Of these, an internet-based RCT using Active Living Every
Day (ALED) and pedometers found reductions in triglycerides
(P = 0.01) and slight reductions in LDL and TC, resulting in
a lower coronary risk ratio (CRR). Fasting glucose in this
16 week study did not change (P = 0.92).14 Our study followed
participants for a substantially longer time period, which could
account for the reduction in blood glucose measures. In the
First Step Program (FSP), a pedometer-based intervention,
47 overweight/obese sedentary individuals increased their
activity at 16 and 24 weeks, but no significant changes were
noted for glycemia, BP, or cholesterol values.12 In a study by
de Greef et al,16 41 type 2 diabetics were randomized to a
control group or an intervention group consisting of 5 group

Table 2 Change in blood pressure and lipids*
Characteristics

Standard care
(n = 40)

Group
(n = 44)

Armband
(n = 41)

Group + armband
(n = 39)

P-Value†

Change in resting systolic BP (mm Hg)
Change in resting diastolic BP (mm Hg)
Change in total cholesterol (mg/dL)
Change in HDL (mg/dL)
Change in LDL (mg/dL)
Change in triglycerides (mg/dL)

0.57 (1.18)

−2.96 (1.12)‡
−0.42 (0.75)
15.58 (5.28)‡
3.28 (2.50)
13.71 (5.02)‡
−7.68 (6.36)

−2.24 (1.16)
−0.83 (0.78)
3.06 (5.50)
3.52 (2.60)
2.67 (5.23)
−13.07 (6.61)‡

−3.48 (1.20)‡
−1.41 (0.80)
3.61 (5.62)
3.33 (2.66)
3.96 (5.34)
−19.87 (6.81)‡

0.08
0.64
0.11
1.00
0.18
0.26

−0.01 (0.79)
18.32 (5.57)‡
2.66 (2.63)
15.84 (5.30)‡
−1.34 (6.72)

Notes: *Values are least-squares means (SE) adjusted for baseline age, gender, race, education, recruitment wave, medication, and baseline blood pressure or lipids value.
†
Differences in blood lipids change across groups (row P values), ‡within-groups were tested by analysis of covariance (ANCOVA) (P , 0.05), and § Significant across group
differences were followed by pair-wise comparisons to test whether intervention groups differed significantly from the standard care group (P , 0.05).
Abbreviations: BP, blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein; SE, standard error.
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Change Glucose (mg/dL)

6
4
2

1.99

0
–2

*

–4

–5.42

–6

*

–8

–8.88

–10
–12

*
–12.59

–14

Physiological mechanisms

–16
–18
Standard care

Group

Armband Group+Armband

Figure 2 Mean change (least-squares mean ± 95% confidence interval) in fasting
glucose for the standard care and intervention groups. Difference across groups
were tested by analysis of covariance (ANCOVA) with adjustment for prespecified
covariates (baseline age, gender, race, education, recruitment wave, and baseline
glucose) among 152 participants not taking glucose medication. Significant
ANCOVAs (P , 0.05) were followed by pair-wise comparisons to test whether
intervention groups differed significantly from the standard care group.
Notes: *The P-values for pairwise comparisons of standard care with the armband,
group, and group + armband were P , 0.05 for each.

sessions in 12 weeks, and a booster session at 22 weeks plus
a pedometer. At the 1-year follow up, results indicated no
significant changes in TC or BP, but there was a significant
decrease in HbA1c within both groups,16 which agrees with
our findings. Lastly, in the “Walking for Wellbeing in the
West” study, while triglycerides and glucose were not measured, no differences were found for TC, HDL, or BP between
or within the intervention or control groups.17 Overall, our
findings are comparable with the existing literature.12,14,16,17,19,20
Most studies found no changes to cholesterol levels.12,16,17,19,20
Our findings for glycemic values agreed with one study we
reviewed that dealt with technology,16 but not with findings
of other studies.12,14,17,19 Even so, it is recognized that being
physically active is associated with reducing glucose levels.29
We found very little change in BP values, which was consistent
with the studies presented.12,14,16,17
The technology-based real-time monitoring used in LEAN
is an example of a new type of self-monitoring. Traditional
paper-based PA self-monitoring has demonstrated benefits
in the past.12,30 With the advent of technological resources
and the widespread availability of computers and web-based
cell phones, the shift from paper to more advanced devices
can provide flexibility in how data such as PA measures and
energy expenditure are displayed and used for reinforcement
of behavior change. Augmenting weight-loss interventions
with real-time measurements and increased accessibility

192

to PA history supports cognitive restraint from sedentary
behaviors or improper food consumption by integrating
constant reinforcement toward program goals.30 The value and
success of using technology-based methods may be attributable to the interactive experience associated with accessing
information. This methodology can support users via tailored
feedback and cues to assess and enhance their PA levels while
tracking progress toward personalized goals. Further study on
this tailoring is needed to enhance PA behavior change and
maintain adherence to healthy lifestyle programs.
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PA is known to influence several factors that may lower the
levels of fasting blood glucose. Of primary importance is
increasing insulin sensitivity and decreasing insulin resistance, resulting in improved metabolic responses when
shuttling nutrients for glucose storage and usage.31,32 Habitual
exercise has also been shown to increase citrate synthase and
cellular GLUT-4 protein expression, each of which increases
the uptake of glucose into the skeletal muscle.33,34 This can
directly clear glucose more effectively from the blood stream.
Weight loss itself has also been linked to lower glucose
levels in the blood.35 These physiologic responses together
can explain why lower levels of fasting glucose were found.
Modest blood pressure reduction has been found with those
participating in regular exercise, though persons who are
in stage 1 or 2 hypertension may benefit more than those
who are normotensive.36 Due to our population being in
the latter category, we did not find great reductions in
BP values. Greater improvements in these cardiometabolic
risk factors may be more likely seen in those with either
consistent or higher levels of energy expenditure in combination with diet interventions such as those in the HEED
program materials.26

Strengths and limitations
This study had several strengths, including the randomized
design, the blinding of assessment staff to group assignments,
the moderate length of follow-up, the quantitative measures
used to assess the outcomes, and the large proportion of
African Americans, lending diversity to our study population. This study was structured to allow comparisons with
4 different conditions, allowing detailed comparisons among
different treatment modalities, including historically successful and future strategies. These results have probable
implications for future commercialization and community
interest in a minimal contact, widely dispersible alternative
to group-based weight loss campaigns, which are relatively
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expensive. Our results may stimulate new intervention
approaches to increase PA, with the result of lowering fasting glucose.
Limitations include large attrition rates in the standard
care group (48% attrition rate), though this was similar in
all groups. Most of the participants in the LEAN study were
female (82%), and had a high level of education (college
or above, 77%). This limits our results to similar populations. Information on changes or end of study prescription
medication for BP, lipids, or glucose was not available. This
may present a concern from internal validity threats due to
the confounding nature of these substances on our outcome
measures. However, assumptions were made that few persons
on medication would enter or exit medication therapy or have
their prescription changed dramatically. Due to costs, we only
measured the cardiometabolic risk factors at baseline and
month 9. We were not able to examine the relationship of the
glucose, or the other values, with time. We suggest that future
studies allow for several measurement points to investigate
this relationship when using technology-based methods.

Conclusions
In this study of sedentary, overweight or obese men and
women, all three treatments using group or armband conditions reduced fasting glucose levels when compared with
standard care. No changes were found for BP or blood
lipids between the standard care and treatment conditions.
Our study suggests that the incorporation of armband technology into weight loss interventions can be an effective
strategy to lower fasting glucose. This illustrates the value
of utilizing real-time self-monitoring systems for measuring energy expenditure in future programs. Automated
devices, such as the armband, can be a successful way to
disseminate healthy lifestyle programs that can improve
important health risk factors. This can be accomplished
without group-based behavioral programs, thereby potentially reducing costs.
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